This may be years down the road but I'd like to know so I can fasttrack my dementia prevention program. What does your doctor think and what is their dementia prevention program? Does your doctor remember your 33% chance of getting dementia/Alzheimers post stroke.
My program here:
1. Fish Oil Might Guard Against Loss of Brain Cells
2. Shakespeare and Wordsworth boost the brain, new research reveals
3. Physical activity is beneficial for late-life cognition
4. Omega 3 fatty acid for the prevention of cognitive decline and dementia
5. To keep sharp, retirees need to find a purpose
6. Keep Working to Keep Dementia at Bay.
7. Preliminary medical testing results have shown that aspirin may prevent dementia and intestinal cancers
8. THC(marijuana) may benefit those with Alzheimer’s disease.
9. Common BP Drugs Tied to Lower Risk of Alzheimer's
10. Study: Fruits and veggies may prevent dementia
11. Coffee May Lower Your Risk of Dementia
12. Light-to-moderate alcohol consumption, in comparison with abstinence, was associated with approximately 35-45% lower risk of cognitive decline or dementia.
13. Activation of neuronal nicotinic acetylcholine receptors (nAChRs) has been shown to maintain cognitive function following aging or the development of dementia.
14. Overeating is associated with an increased risk of mild cognitive impairment (MCI) in people 70 or older
15. To Stave off Alzheimer’s, Stay Hungry?
16. Calorie Restriction Prevents Neurodegeneration
17. Researchers: Mini-Fast Prevents Alzheimer's
18. Evidence-Based Medicinal Properties of Coconut Oil - brain boosting
19. Dementia Prevention – What Can Be Done? The generic medical version
I bet your doctor gives you this.
I however am not going to wait for doctors and researchers to come up with a solution. You are going to have to read and decide for yourself how you want to approach dementia prevention. I doubt your doctor will be any help.
The possible test here:
http://www.nature.com/nm/journal/v20/n4/abs/nm.3466.html
- Nature Medicine
- 20,
- 415–418
- doi:10.1038/nm.3466
- Received
- Accepted
- Published online
Alzheimer's
disease causes a progressive dementia that currently affects over 35
million individuals worldwide and is expected to affect 115 million by
2050 (ref. 1).
There are no cures or disease-modifying therapies, and this may be due
to our inability to detect the disease before it has progressed to
produce evident memory loss and functional decline. Biomarkers of
preclinical disease will be critical to the development of
disease-modifying or even preventative therapies2. Unfortunately, current biomarkers for early disease, including cerebrospinal fluid tau and amyloid-β levels3, structural and functional magnetic resonance imaging4 and the recent use of brain amyloid imaging5 or inflammaging6,
are limited because they are either invasive, time-consuming or
expensive. Blood-based biomarkers may be a more attractive option, but
none can currently detect preclinical Alzheimer's disease with the
required sensitivity and specificity7.
Herein, we describe our lipidomic approach to detecting preclinical
Alzheimer's disease in a group of cognitively normal older adults. We
discovered and validated a set of ten lipids from peripheral blood that
predicted phenoconversion to either amnestic mild cognitive impairment
or Alzheimer's disease within a 2–3 year timeframe with over 90%
accuracy. This biomarker panel, reflecting cell membrane integrity, may
be sensitive to early neurodegeneration of preclinical Alzheimer's
disease.
No comments:
Post a Comment